Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

Dr. Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

The Ohio State University, United States

Author Profiles

Orcid

Google Scholar

Research Gate

Early Academic Pursuits ๐ŸŽ“

Dr. Rituraj Upadhyay began his academic journey with a strong foundation in medical education at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. There, he completed his Bachelor of Medicine and Surgery (MBBS) in 2014, followed by an MD in Radiation Oncology (2017). His early medical training was marked by a deep interest in radiotherapy and oncology, leading him to pursue a Diplomate of National Board (DNB) certification in Radiation Oncology. His academic endeavors during this time reflected a commitment to advancing medical knowledge and improving patient care through radiation oncology.

Professional Endeavors ๐ŸŒ

Dr. Upadhyay’s professional career has been driven by a passion for advancing radiation oncology, particularly through his work in clinical and academic settings. His residency at The Ohio State University Wexner Medical Center (2021โ€“2025) is a notable highlight in his professional journey, demonstrating his commitment to mastering the latest technologies and treatments in radiation oncology. Dr. Upadhyay’s time at renowned institutions like MD Anderson Cancer Center and Rutgers Cancer Institute of New Jersey has further solidified his standing as an emerging leader in the field. His pursuit of innovation and excellence is evident from his involvement in advanced radiation oncology fellowships and international research collaborations.

Contributions and Research Focus ๐Ÿ”ฌ

Dr. Upadhyay’s research is at the forefront of radiation oncology, with a focus on improving treatment outcomes and minimizing side effects. He has contributed significantly to clinical trials and funded research, such as the “PRIMe-STAR trial” on progressive/recurrent intracranial meningiomas and the “AVATAR” system aimed at reducing anesthesia needs in pediatric radiotherapy. His research on stereotactic radiosurgery for brain metastases and radiation therapy for conditions like penile cancer and renal stereotactic ablative therapy underscores his diverse interests in cancer treatment. His studies have potential global impact, as reflected in his leadership role in multinational research endeavors.

Impact and Influence ๐ŸŒŸ

Dr. Upadhyay’s influence extends beyond his research. As an educator and mentor, he actively shapes the next generation of radiation oncologists. His roles in mentoring medical students, residents, and fellows at institutions like The Ohio State University and Massachusetts General Hospital highlight his dedication to guiding aspiring professionals. He also plays a key role in enhancing the field through his involvement in various professional organizations such as the American Society for Radiation Oncology (ASTRO) and the Radiosurgery Society (RSS). His work as a guideline reviewer and committee member for several radiation oncology societies reflects his broad influence on the development of standards and best practices in the field.

Academic Cites ๐Ÿ“š

Dr. Upadhyay’s research and academic work are well-regarded, with his contributions earning recognition through numerous awards and honors. Notable accolades include the American College of Radiation Oncology (ACRO) Best Abstract Award and the American Radium Society (ARS) Early Career Oncologist Award, which are testaments to his influential research on topics like stereotactic radiosurgery and palliative radiation therapy. These accolades further cement his reputation in the academic community, demonstrating the high regard in which his peers hold his research.

Technical Skills ๐Ÿ’ป

Dr. Upadhyay has developed a comprehensive set of technical skills that position him at the cutting edge of radiation oncology. His expertise spans advanced radiation therapy techniques such as stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), proton therapy, and image-guided brachytherapy. In addition, he is well-versed in cutting-edge technologies, including the use of artificial intelligence and machine learning in radiation oncology for treatment planning and quality assurance. His technical acumen is further demonstrated by his involvement in developing new approaches to enhance clinical outcomes for complex cancer cases.

Teaching Experience ๐Ÿ“–

Dr. Upadhyay has dedicated substantial time to teaching and mentorship, sharing his expertise with medical students, residents, and fellow researchers. He has served as a moderator for educational webinars and a mentor for various research initiatives. His roles as a panelist and speaker at international conferences, such as the ASTRO Annual Meeting and the Ohio State University Cardio-Oncology Symposium, reflect his commitment to advancing education within the field of oncology. Through these initiatives, he has played a key role in shaping the future of radiation oncology education.

Legacy and Future Contributions ๐Ÿ”ฎ

Dr. Upadhyay’s legacy in radiation oncology is already being established through his groundbreaking research and mentorship. His involvement in international clinical trials, such as the AVATAR system and the PRIMe-STAR trial, is likely to make a long-lasting impact on the clinical management of cancer patients globally. Looking forward, Dr. Upadhyay plans to continue advancing his research, particularly in the areas of stereotactic radiosurgery and precision medicine. His work promises to significantly shape the future of radiation oncology, particularly in improving treatment efficacy, minimizing side effects, and enhancing patient care across diverse populations.

 

Top Noted Publications ๐Ÿ“–

Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas

Authors: Divya Yadav, Rituraj Upadhyay, Vinodh A. Kumar, Melissa M. Chen, Jason M. Johnson, Holly Langshaw, Brandon J. Curl, Maguy Farhat, Wasif Talpur, Thomas H. Beckham et al.

Journal: Practical Radiation Oncology

Year: 2024

Risk-Stratified Radiotherapy in Pediatric Cancer

Authors: Rituraj Upadhyay, Arnold C. Paulino

Journal: Cancers

Year: 2024

Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients

Authors: Rituraj Upadhyay, Brett Klamer, Jennifer Matsui, Vikram B. Chakravarthy, Thomas Scharschmidt, Nicholas Yeager, Bhuvana A. Setty, Timothy P. Cripe, Ryan D. Roberts, Jennifer H. Aldrink et al.

Journal: Cancers

Year: 2024

Quantifying the Risk and Dosimetric Variables of Symptomatic Brainstem Injury after Proton Beam Radiation in Pediatric Brain Tumors

Authors: Rituraj Upadhyay, Kaiping Liao, David R Grosshans, Susan L McGovern, Mary Frances McAleer, Wafik Zaky, Murali M Chintagumpala, Anita Mahajan, Debra Nana Yeboa, Arnold C Paulino

Journal: Neuro-Oncology

Year: 2022

Patterns of Failure after Radiation Therapy in Primary Spinal High-Grade Gliomas: A Single Institutional Analysis

Authors: Rituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, Arnold C Paulino, Mary Frances McAleer, Amol Ghia, Jing Li, Debra Nana Yeboa, Monica Loghin, Rebecca Harrison et al.

Journal: Neuro-Oncology Advances

Year: 2022

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

๐Ÿ‘จโ€๐ŸŽ“ Professional Profile

๐ŸŽ“ Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

๐Ÿข Professional Endeavors

Dr. Vaughanโ€™s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for womenโ€™s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

๐ŸŒŸ Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

๐ŸŒ Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

๐Ÿ“š Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

๐Ÿ”ง Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

๐Ÿ‘ฉโ€๐Ÿซ Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

๐Ÿ… Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

๐Ÿ“– Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021